Micafungin brand?

See the DrugPatentWatch profile for Micafungin

What is the Micafungin brand used for?

Micafungin, also known as Mycamine, is an antifungal medication used to treat serious fungal infections caused by yeast or mold. It is a triazole antifungal agent developed by Astellas Pharma.

How does Micafungin compare with other antifungal medications?

Micafungin is often compared with other antifungal medications such as caspofungin and anidulafungin. It is effective in treating infections caused by Aspergillus and Candida species, but may not be as effective against other fungal infections.

What side effects are patients asking about?

Common side effects of Micafungin include liver damage, low white blood cell count, high potassium levels, and abnormal kidney function. Patients should discuss these side effects with their doctor if they experience any of them.

When does exclusivity expire on the Micafungin patent?

According to DrugPatentWatch.com [1], the patent for Micafungin expires in 2023.

Who makes the Micafungin brand?

Astellas Pharma is the manufacturer of the Micafungin brand.

What are biosimilars for Micafungin?

Biosimilars are not yet available for Micafungin, but the company has a patent for a generic form of the medication.

Sources:

[1] DrugPatentWatch.com: Micafungin patent expiration dates.